Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia

Abstract

These differences are unlikely to be solely due to medication effects, and reduced GM volume in treatment-resistant schizophrenia may represent an accelerated disease course or a different underlying pathology.